CTSU response
Response from CTSU to Congressmen Dingell and Stupak
1. Response to your letters about our work on ezetimibe: September 16, 2008
Letters about CTSU from Congressmen Dingell and Stupak
2. Letter 2: September 2, 2008
3. Attachment to Letter 2: CTSU 21 July report to the FDA
Attachment to Letter 2 (Tables)
Other relevant links
1. CTSU guidelines for honoraria, etc
2. Peto R et al “Analyses of Cancer Data from Three Ezetimibe Trials.” NEJM 2008: 359 (10.1056/NEJMsa0806603). Available from www.nejm.org